HIV News and Research

RSS

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

In Africa and Thailand, communities that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study presented this week at the Conference on Retroviruses and Opportunistic Infections in Atlanta.

6 Mar 2013

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

"Results of a major HIV prevention trial suggest that daily use of a product -- whether a vaginal gel or an oral tablet -- does not appear to be the right approach for preventing HIV in young, unmarried African women," a press release from the Microbicide Trials Network reports.

6 Mar 2013

Viewpoints: Disappointing 'surprises' in health law; Cuts in graduate medical training threatens physician supply; Va. can afford Medicaid expansion

The proposed 2.3 percent reduction in (Medicare Advantage plan) payments, which comes on top of cuts already scheduled under the Affordable Care Act, pays no mind to the potential impact on quality of care throughout the program. These cuts will apply to all plans no matter the value they bring in providing quality care to beneficiaries or offering innovative solutions that could ultimately be scaled and applied to the broader program.

5 Mar 2013

GlobalPost reports on IOM evaluation of PEPFAR

GlobalPost reports on "an independent evaluation of the President's Emergency Program for AIDS Relief (PEPFAR), released February 20 by the Institute of Medicine (IOM)," writing that the report "lauded the program's achievements as proof that HIV services can be delivered successfully on a large scale" and "also recommended several changes to the program, to ensure that the HIV/AIDS response is sustainable."

5 Mar 2013

U.S. researchers report 'functional cure' for infant born with HIV

"A baby born with the virus that causes AIDS appears to have been cured, scientists announced Sunday, describing the case of a child from Mississippi who's now two and a half and has been off medication for about a year with no signs of active infection," the Associated Press reports.

5 Mar 2013

Special envoy for malaria Ray Chambers to help secure investment for achieving health-related MDGs

"Secretary-General Ban Ki-moon has tasked Ray Chambers, who has served as his special envoy for malaria since 2008, with promoting and securing greater investment to achieve the health-related targets within the Millennium Development Goals (MDGs)," the U.N. News Centre reports.

5 Mar 2013

Discovery provides clues for potentially eliminating HIV infection in children

A two-year-old child born with HIV infection and treated with antiretroviral drugs beginning in the first days of life no longer has detectable levels of virus using conventional testing despite not taking HIV medication for 10 months, according to findings presented today at the Conference on Retroviruses and Opportunistic Infections in Atlanta.

5 Mar 2013

HIV might promote aging and disease progression in people with HCV, study results suggest

Infectious disease experts at Johns Hopkins have found that among people infected with the hepatitis C virus, co-infection with HIV, speeds damage and scarring of liver tissue by almost a decade.

5 Mar 2013

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Three antiretroviral-based strategies intended to prevent HIV infection among women did not prove effective in a major clinical trial in Africa.

5 Mar 2013

Results of two important studies published in March issue of AIDS

The results of two important studies have been published in the March issue of AIDS, the official journal of the International AIDS Society. One study notes that screening for HIV should be performed more frequently—up to every three months for the highest-risk patients, while low-risk groups to be tested every three years. A second study demonstrates a link between heavy drinking and risky behaviors for men who have sex with men (MSM).

5 Mar 2013

World Trade Organization meeting this week to discuss proposed extension of TRIPS transition period for LDCs

"On March 5-6, the Trade-Related Aspects of Intellectual Property Rights Council of the World Trade Organization will meet in Geneva to seal the fate of the proposal lengthening the TRIPS transition period for the 49 least-developed countries [LDCs]," Devex's "The Development Newswire" reports, noting, "The transition period, set to expire July 2013, exempts LDCs from the terms of the TRIPS agreement on patents and test data protection for pharmaceuticals."

5 Mar 2013

Study highlights long-term benefits of early antiretroviral therapy initiated in infants

A study led by University of Massachusetts Medical School professor and immunologist Katherine Luzuriaga, MD, and Johns Hopkins Children's Center virologist Deborah Persaud, MD, highlights the long-term benefits of early antiretroviral therapy (ART) initiated in infants.

5 Mar 2013

Express Scripts finds decline in 2012 U.S. spending on traditional prescription drugs

For the first time in more than 20 years, there was a decrease in 2012 U.S. spending on traditional prescription drugs — primarily pills people take to treat more common diseases such as high cholesterol and high blood pressure — according to new data released today by Express Scripts.

5 Mar 2013

People with variations in FTO gene could be at increased risk of melanoma

The research shows that people with particular variations in a stretch of DNA within the FTO gene, called intron 8, could be at greater risk of developing melanoma.

5 Mar 2013

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).

5 Mar 2013

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Pfizer Inc. presented today the results from a Phase 3 study demonstrating the immunogenicity, tolerability and safety of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine Diphtheria CRM197 Protein)in adults infected with human immunodeficiency virus (HIV).

5 Mar 2013

WomanCare Global, Evofem enter strategic alliance

Evofem announced today that it has entered into a strategic alliance with WomanCare Global. Through this alliance, WomanCare Global will provide sales, marketing and global distribution for a selection of Evofem's products, including Softcup and Amphora.

4 Mar 2013

HIV infection may increase risk of acute myocardial infarction

A study that analyzed data from more than 82,000 veterans suggests that infection with the human immunodeficiency virus (HIV) was associated with an increased risk of acute myocardial infarction (AMI, heart attack) beyond what is explained by recognized risk factors, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

4 Mar 2013

Médecins Sans Frontières’ concerns over TPP negotiations

As closed-door talks for the Trans-Pacific Partnership (TPP) Agreement resume in Singapore this week, international medical humanitarian organisation Médecins Sans Frontières is calling on Australia and negotiating countries to reject rules that threaten to dismantle internationally agreed public health safeguards and restrict access to medicines in developing countries.

4 Mar 2013

Older patients with head and neck cancers less likely to die in high-volume hospitals

A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced their survival.

4 Mar 2013

HIV News and Research

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

Viewpoints: Disappointing 'surprises' in health law; Cuts in graduate medical training threatens physician supply; Va. can afford Medicaid expansion

GlobalPost reports on IOM evaluation of PEPFAR

U.S. researchers report 'functional cure' for infant born with HIV

Special envoy for malaria Ray Chambers to help secure investment for achieving health-related MDGs

Discovery provides clues for potentially eliminating HIV infection in children

HIV might promote aging and disease progression in people with HCV, study results suggest

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Results of two important studies published in March issue of AIDS

World Trade Organization meeting this week to discuss proposed extension of TRIPS transition period for LDCs

Study highlights long-term benefits of early antiretroviral therapy initiated in infants

Express Scripts finds decline in 2012 U.S. spending on traditional prescription drugs

People with variations in FTO gene could be at increased risk of melanoma

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

WomanCare Global, Evofem enter strategic alliance

HIV infection may increase risk of acute myocardial infarction

Médecins Sans Frontières’ concerns over TPP negotiations

Older patients with head and neck cancers less likely to die in high-volume hospitals

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News